Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).

Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, Giannantoni A, Blefari F, Carini M, Minervini A, Ginepri A, Salvia G, Vespasiani G, Santelli G, Cimino S, Allegro R, Collura Z, Fragalà E, Arnone S, Pareo RM.

Prostate. 2014 Nov;74(15):1471-80. doi: 10.1002/pros.22866. Epub 2014 Aug 23.

PMID:
25154739
2.

Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.

Suardi N, Gandaglia G, Nini A, Montorsi F, Pellucchi F, Agostini A, Rigatti P.

Minerva Urol Nefrol. 2014 Jun;66(2):119-25.

PMID:
24988203
3.

Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies.

Oelke M, Berges R, Schläfke S, Burkart M.

World J Urol. 2014 Oct;32(5):1149-54. doi: 10.1007/s00345-014-1338-x. Epub 2014 Jun 18.

PMID:
24938176
4.
5.

An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst® Gold Study.

Cai T, Morgia G, Carrieri G, Terrone C, Imbimbo C, Verze P, Mirone V; IDIProst® Gold Study Group.

Arch Ital Urol Androl. 2013 Dec 31;85(4):184-9. doi: 10.4081/aiua.2013.4.184.

6.

A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.

Coulson S, Rao A, Beck SL, Steels E, Gramotnev H, Vitetta L.

Complement Ther Med. 2013 Jun;21(3):172-9. doi: 10.1016/j.ctim.2013.01.007. Epub 2013 Feb 23.

PMID:
23642948
7.

Electroacupuncture for moderate and severe benign prostatic hyperplasia: a randomized controlled trial.

Wang Y, Liu B, Yu J, Wu J, Wang J, Liu Z.

PLoS One. 2013 Apr 12;8(4):e59449. doi: 10.1371/journal.pone.0059449. Print 2013.

8.
9.

Isoflavones in treating watchful waiting benign prostate hyperplasia: a double-blinded, randomized controlled trial.

Wong WC, Wong EL, Li H, You JH, Ho S, Woo J, Hui E.

J Altern Complement Med. 2012 Jan;18(1):54-60. doi: 10.1089/acm.2010.0077.

PMID:
22268969
10.
11.

Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.

Lee JY, Foster HE Jr, McVary KT, Meleth S, Stavris K, Downey J, Kusek JW.

J Altern Complement Med. 2011 May;17(5):469-72. doi: 10.1089/acm.2010.0300. Epub 2011 May 9.

12.

Analysis of the results obtained with a new phytotherapeutic association for LUTS versus control. [corrected].

Bercovich E, Saccomanni M.

Urologia. 2010 Jul-Sep;77(3):180-6. Erratum in: Urologia. 2010 Oct-Dec;77(4):287.

PMID:
20931547
13.

Symptomatic comparison in efficacy on patients with benign prostatic hyperplasia treated with two therapeutic approaches.

Li S, Lu A, Wang Y.

Complement Ther Med. 2010 Feb;18(1):21-7. doi: 10.1016/j.ctim.2009.10.002. Epub 2009 Dec 2.

PMID:
20178875
14.

Clinical efficacy of acupuncture on the morphine-related side effects in patients undergoing spinal-epidural anesthesia and analgesia.

Jiang YH, Jiang W, Jiang LM, Lin GX, Yang H, Tan Y, Xiong WW.

Chin J Integr Med. 2010 Feb;16(1):71-4. doi: 10.1007/s11655-010-0070-7. Epub 2010 Feb 4.

PMID:
20131040

Supplemental Content

Loading ...
Support Center